VYOME HOLDINGS, INC. Customer Advances, Current
VYOME HOLDINGS, INC. (HIND) had Customer Advances, Current of $40.10 thousand as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Notes
us-gaap:CustomerAdvancesCurrent · last filed 2026-08-12
- 2026-06-30: Customer Advances, Current $40.10K.
- 2026-03-31: Customer Advances, Current $24.84K.
- 2025-12-31: Customer Advances, Current $26.09K.
- 2024-12-31: Customer Advances, Current $38.36K.
| Period end | Customer Advances, Current |
|---|---|
| 2026-06-30 | $40.10K 10-Q · filed 2026-08-12 |
| 2026-03-31 | $24.84K 10-Q · filed 2026-05-12 |
| 2025-12-31 | $26.09K 10-Q · filed 2026-08-12 |
| 2024-12-31 | $38.36K 10-K · filed 2026-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |